Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Sub-tenon

Other

Phase 2 Most advanced trial (none active)

What is Sub-tenon?

Sub-tenon injection of hyaluronidase (HA) alone is given into the sub-Tenon space of the eye at a total volume of 1.1 ml. It is studied in thyroid eye disease (Graves ophthalmopathy).

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Other
Therapy area
Ophthalmology
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 2

Conditions studied

Thyroid Eye Disease

Sources

Updated Oct 25, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.